Your browser doesn't support javascript.
loading
Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation.
Anan, Go; Hirose, Takuo; Kikuchi, Daisuke; Takahashi, Chika; Endo, Akari; Ito, Hiroki; Sato, Shigemitsu; Nakayama, Shingo; Hashimoto, Hideaki; Ishiyama, Katsuya; Kimura, Tomoyoshi; Takahashi, Kazuhiro; Sato, Makoto; Mori, Takefumi.
Afiliación
  • Anan G; Department of Urology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Urology, Yotsuya Medical Cube, Tokyo, Japan.
  • Hirose T; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Division of Integrative Renal Replacement Therapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate S
  • Kikuchi D; Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
  • Takahashi C; Division of Integrative Renal Replacement Therapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Endo A; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Ito H; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sato S; Division of Integrative Renal Replacement Therapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Nakayama S; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Hashimoto H; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Ishiyama K; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Kimura T; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Takahashi K; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sato M; Department of Urology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Mori T; Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Division of Integrative Renal Replacement Therapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Pharmacol Res ; 186: 106524, 2022 12.
Article en En | MEDLINE | ID: mdl-36349594
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cálculos Renales / Diabetes Mellitus / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cálculos Renales / Diabetes Mellitus / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos